CETP inhibitors
Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Ali, Amjad Hunt, Julianne A Kallashi, Florida Kowalchick, Jennifer Kim, Dooseop Smith, Cameron J Sinclair, Peter J Sweis, Ramzi F Taylor, Gayle E Thompson, Christopher F Chen, Liya Quraishi, Nazia |
| description | Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08334290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08334290</sourcerecordid><originalsourceid>FETCH-uspatents_grants_083342903</originalsourceid><addsrcrecordid>eNrjZOB3dg0JUMjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDC2NjEyNLAmAglAEyrH2U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CETP inhibitors</title><source>USPTO Issued Patents</source><creator>Ali, Amjad ; Hunt, Julianne A ; Kallashi, Florida ; Kowalchick, Jennifer ; Kim, Dooseop ; Smith, Cameron J ; Sinclair, Peter J ; Sweis, Ramzi F ; Taylor, Gayle E ; Thompson, Christopher F ; Chen, Liya ; Quraishi, Nazia</creator><creatorcontrib>Ali, Amjad ; Hunt, Julianne A ; Kallashi, Florida ; Kowalchick, Jennifer ; Kim, Dooseop ; Smith, Cameron J ; Sinclair, Peter J ; Sweis, Ramzi F ; Taylor, Gayle E ; Thompson, Christopher F ; Chen, Liya ; Quraishi, Nazia ; Merck Sharp & Dohme Corp</creatorcontrib><description>Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8334290$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64037</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8334290$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ali, Amjad</creatorcontrib><creatorcontrib>Hunt, Julianne A</creatorcontrib><creatorcontrib>Kallashi, Florida</creatorcontrib><creatorcontrib>Kowalchick, Jennifer</creatorcontrib><creatorcontrib>Kim, Dooseop</creatorcontrib><creatorcontrib>Smith, Cameron J</creatorcontrib><creatorcontrib>Sinclair, Peter J</creatorcontrib><creatorcontrib>Sweis, Ramzi F</creatorcontrib><creatorcontrib>Taylor, Gayle E</creatorcontrib><creatorcontrib>Thompson, Christopher F</creatorcontrib><creatorcontrib>Chen, Liya</creatorcontrib><creatorcontrib>Quraishi, Nazia</creatorcontrib><creatorcontrib>Merck Sharp & Dohme Corp</creatorcontrib><title>CETP inhibitors</title><description>Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZOB3dg0JUMjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDC2NjEyNLAmAglAEyrH2U</recordid><startdate>20121218</startdate><enddate>20121218</enddate><creator>Ali, Amjad</creator><creator>Hunt, Julianne A</creator><creator>Kallashi, Florida</creator><creator>Kowalchick, Jennifer</creator><creator>Kim, Dooseop</creator><creator>Smith, Cameron J</creator><creator>Sinclair, Peter J</creator><creator>Sweis, Ramzi F</creator><creator>Taylor, Gayle E</creator><creator>Thompson, Christopher F</creator><creator>Chen, Liya</creator><creator>Quraishi, Nazia</creator><scope>EFH</scope></search><sort><creationdate>20121218</creationdate><title>CETP inhibitors</title><author>Ali, Amjad ; Hunt, Julianne A ; Kallashi, Florida ; Kowalchick, Jennifer ; Kim, Dooseop ; Smith, Cameron J ; Sinclair, Peter J ; Sweis, Ramzi F ; Taylor, Gayle E ; Thompson, Christopher F ; Chen, Liya ; Quraishi, Nazia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_083342903</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ali, Amjad</creatorcontrib><creatorcontrib>Hunt, Julianne A</creatorcontrib><creatorcontrib>Kallashi, Florida</creatorcontrib><creatorcontrib>Kowalchick, Jennifer</creatorcontrib><creatorcontrib>Kim, Dooseop</creatorcontrib><creatorcontrib>Smith, Cameron J</creatorcontrib><creatorcontrib>Sinclair, Peter J</creatorcontrib><creatorcontrib>Sweis, Ramzi F</creatorcontrib><creatorcontrib>Taylor, Gayle E</creatorcontrib><creatorcontrib>Thompson, Christopher F</creatorcontrib><creatorcontrib>Chen, Liya</creatorcontrib><creatorcontrib>Quraishi, Nazia</creatorcontrib><creatorcontrib>Merck Sharp & Dohme Corp</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ali, Amjad</au><au>Hunt, Julianne A</au><au>Kallashi, Florida</au><au>Kowalchick, Jennifer</au><au>Kim, Dooseop</au><au>Smith, Cameron J</au><au>Sinclair, Peter J</au><au>Sweis, Ramzi F</au><au>Taylor, Gayle E</au><au>Thompson, Christopher F</au><au>Chen, Liya</au><au>Quraishi, Nazia</au><aucorp>Merck Sharp & Dohme Corp</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CETP inhibitors</title><date>2012-12-18</date><risdate>2012</risdate><abstract>Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_08334290 |
| source | USPTO Issued Patents |
| title | CETP inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A47%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ali,%20Amjad&rft.aucorp=Merck%20Sharp%20&%20Dohme%20Corp&rft.date=2012-12-18&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08334290%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |